ReviewJournal of fungi (Basel, Switzerland)2021

Ibrexafungerp: A First-in-Class Oral Triterpenoid Glucan Synthase Inhibitor.

Sabelle Jallow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.